Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2023)

Verano Holdings' (VRNO) quarterly Gains from Investment Securities came in at -$3.5 million in Q1 2023, up 27.18% year-on-year from -$2.7 million in Q1 2022, and down 365.86% on a QoQ basis from -$744000.0 in Q4 2022.

Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2023) Analysis & Trends

Verano Holdings (VRNO) has 3 years of Gains from Investment Securities data on file, last reported at -$3.5 million in Q1 2023.

  • On a quarterly basis, Gains from Investment Securities rose 27.18% year-over-year to -$3.5 million in Q1 2023; TTM through Dec 2023 was -$3.5 million, a 71.13% increase from a year earlier, with the FY2023 full-year figure at -$3.5 million, up 76.37% from the prior year.
  • Gains from Investment Securities for Q1 2023 stood at -$3.5 million, down from -$744000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for VRNO reached as high as $1.2 million in Q3 2021 and fell as low as -$6.0 million in Q2 2022.
  • Historically, Gains from Investment Securities has averaged -$2.7 million across 3 years, with a median of -$3.5 million in 2023.
  • On a YoY basis, Gains from Investment Securities climbed as much as 83.84% in 2022 and fell as far as 141.42% in 2022.
  • Year by year, Gains from Investment Securities stood at -$4.6 million in 2021, then jumped by 83.84% to -$744000.0 in 2022, then slumped by 365.86% to -$3.5 million in 2023.
  • Per Business Quant data, the three most recent Gains from Investment Securities figures were -$3.5 million in Q1 2023, -$744000.0 in Q4 2022, and -$502000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Verano Holdings 1.99 Bn 1.91 Bn 98.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.47 Mn
Mar 31, 2023 -3.47 Mn
Dec 31, 2022 -744,000.00
Dec 31, 2022 -744,000.00
Sep 30, 2022 -502,000.00
Sep 30, 2022 -502,000.00
Jun 30, 2022 -6.00 Mn
Jun 30, 2022 -6.00 Mn
Mar 31, 2022 -4.76 Mn
Mar 31, 2022 -4.76 Mn
Dec 31, 2021 -4.60 Mn
Dec 31, 2021 -4.60 Mn
Sep 30, 2021 1.21 Mn
Sep 30, 2021 1.21 Mn